Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The prolactin response to intravenous clomipramine, a 5-HT uptake inhibitor, was significantly attenuated in 12 patients with major depression. In contrast, in a further 12 depressed patients, the PRL responses to thyrotropin-releasing hormone, which acts directly on the pituitary to release PRL, were not reduced. These findings suggest that the reduction in 5-HT-mediated PRL release seen in depressed patients is due to an impairment of brain 5-HT function rather than a pituitary abnormality.

Type

Journal article

Journal

Br J Psychiatry

Publication Date

03/1992

Volume

160

Pages

372 - 378

Keywords

Adult, Brain, Clomipramine, Depressive Disorder, Female, Humans, Infusions, Intravenous, Male, Personality Inventory, Prolactin, Receptors, Serotonin, Serotonin, Thyrotropin-Releasing Hormone